Randomized Controlled Trial
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 319-333
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.319
Figure 1
Figure 1 Total Cancer Fatigue Scale scores before and after intervention. Intra-group comparison before and after intervention: bP < 0.01 vs baseline; cP < 0.01 vs 3 mo. Comparison between experimental group and control group at different time points: dP < 0.05, eP < 0.01, experimental group vs control group at baseline/3 mo/6 mo.
Figure 2
Figure 2 P300 latency and amplitude changes. A: P300 latency change; B: P300 amplitude change. Intra-group comparison before and after intervention: bP < 0.01 vs baseline; cP < 0.01 vs 3 mo. Comparison between experimental group and control group at different time points: dP < 0.05, eP < 0.01, experimental group vs control group at baseline/3 mo/6 mo.
Figure 3
Figure 3 Functional assessment of cancer therapy. A: Functional assessment of cancer therapy-cognitive function total score change before and after intervention. Intra-group comparison before and after intervention: bP < 0.01 vs baseline; cP < 0.01 vs 3 mo. Comparison between experimental group and control group at different time: eP < 0.01, experimental group vs control group at baseline/ 3 mo/ 6 mo; B: Functional assessment of cancer therapy – colorectal total score changes before and after intervention. Intra-group comparison before and after intervention: bP < 0.01 vs baseline; cP < 0.01 vs 3 mo. Comparison between experimental group and control group at different time: dP < 0.05, eP < 0.01, experimental group vs control group at baseline/ 3 mo/ 6 mo.